特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

てんかん:疫学的予測

Epilepsy -Epidemiology Forecast to 2028

発行 DelveInsight Business Research LLP 商品コード 565332
出版日 ページ情報 英文 50 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
てんかん:疫学的予測 Epilepsy -Epidemiology Forecast to 2028
出版日: 2019年01月01日 ページ情報: 英文 50 Pages
概要

当レポートでは、世界の癲癇の疫学的予測について分析し、疾患の概要や現在の治療手法/アルゴリズム、世界全体および主要国 (米国・欧州諸国・日本) での有病者数の動向見通し (通算12年間分)、サブタイプ別の詳細動向、今後の市場機会・医薬品開発の見通しなどについて調査しております。

第1章 イントロダクション

第2章 疾患の背景事情

  • イントロダクション
  • 病因
  • 症状
  • 分類
  • リスク要因
  • 診断方法
  • てんかんと結節性硬化症 (TSC) 突然変異
  • 現在の治療方法と臨床診療

第3章 疫学と患者人口

  • 分析のポイント
  • 米国
    • てんかんの有病者数
    • 男女別の有病者数
    • サブタイプ別の有病者数
    • TSC (結節性硬化症) に伴うてんかんの有病者数
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
  • 日本

第4章 付録

  • 分析手法

第5章 コンサルティングサービス

第6章 免責事項

第7章 DelveInsightについて

図表

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Epilepsy in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Epilepsy in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Epilepsy in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Epilepsy in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Epilepsy in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Epilepsy in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Epilepsy in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Epilepsy in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Epilepsy in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Epilepsy in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Epilepsy in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Epilepsy in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Epilepsy in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Epilepsy in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Epilepsy in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Epilepsy in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Epilepsy in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Epilepsy in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Epilepsy in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Epilepsy in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Epilepsy in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Epilepsy in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Epilepsy in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Epilepsy in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Epilepsy in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Epilepsy in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Epilepsy in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Epilepsy in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Epilepsy in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Epilepsy in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Epilepsy in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Epilepsy in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Epilepsy in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Epilepsy in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Epilepsy in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Epilepsy in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Epilepsy in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Epilepsy in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Epilepsy in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Epilepsy in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Epilepsy in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Epilepsy in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Epilepsy in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Epilepsy in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Epilepsy in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Epilepsy in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Epilepsy in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Epilepsy in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Epilepsy in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Epilepsy in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Epilepsy in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Epilepsy in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Epilepsy in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Epilepsy in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Epilepsy in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Epilepsy in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Epilepsy in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Epilepsy in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Epilepsy in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Epilepsy in Japan (2016-2028)
目次
Product Code: DIEI0283

DelveInsight's "Epilepsy - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Epilepsy epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Epilepsy Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Epilepsy in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Epilepsy outlook. It also includes the explanation of changing trends of epidemiology outlining the Epilepsy scenario.

Epilepsy Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Epilepsy thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Epilepsy explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Epilepsy Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Epilepsy

Key assessments

  • Patient Segmentation in Epilepsy
  • Epilepsy Risk & Burden
  • Factors driving growth in a specific Epilepsy patient population

Table of Contents

1. Report Introduction

2. Epilepsy Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Epilepsy in 2016
  • 2.2. Patient Share Distribution of Epilepsy in 2028

3. Disease Background and Overview: Epilepsy

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Epilepsy in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Epilepsy in 7MM - By Countries

5. Epidemiology of Epilepsy by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Epilepsy
    • 5.1.3. Sub-Type Specific cases of the Epilepsy *
    • 5.1.4. Sex- Specific Cases of the Epilepsy *
    • 5.1.5. Diagnosed Cases of the Epilepsy
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Epilepsy
    • 5.4.3. Sub-Type Specific cases of the Epilepsy *
    • 5.4.4. Sex- Specific Cases of the Epilepsy *
    • 5.4.5. Diagnosed Cases of the Epilepsy
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Epilepsy
    • 5.5.3. Sub-Type Specific cases of the Epilepsy *
    • 5.5.4. Sex- Specific Cases of the Epilepsy *
    • 5.5.5. Diagnosed Cases of the Epilepsy
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Epilepsy
    • 5.6.3. Sub-Type Specific cases of the Epilepsy *
    • 5.6.4. Sex- Specific Cases of the Epilepsy *
    • 5.6.5. Diagnosed Cases of the Epilepsy
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Epilepsy
    • 5.7.3. Sub-Type Specific cases of the Epilepsy *
    • 5.7.4. Sex- Specific Cases of the Epilepsy *
    • 5.7.5. Diagnosed Cases of the Epilepsy
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Epilepsy
    • 5.8.3. Sub-Type Specific cases of the Epilepsy *
    • 5.8.4. Sex- Specific Cases of the Epilepsy *
    • 5.8.5. Diagnosed Cases of the Epilepsy
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Epilepsy
    • 5.9.3. Sub-Type Specific cases of the Epilepsy *
    • 5.9.4. Sex- Specific Cases of the Epilepsy *
    • 5.9.5. Diagnosed Cases of the Epilepsy

6. Unmet Needs of the Epilepsy

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific